SYGNIS Pharma AG Set to Build on 2008 Achievements to Create Further Growth in 2009

February 5, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Heidelberg, January 14, 2009 – SYGNIS Pharma AG (Frankfurt: LIO; ISIN DE0005043509; Prime Standard) today provided an update on its preparations for the next trial with AX200 in acute stroke as well as highlighting the milestones achieved in 2008.

Twitter
LinkedIn
Facebook
Email
Print

Events Europe